Biote earnings were $28.8M for the trailing 12 months ending Sep 30, 2025, with 175.8% growth year over year. The latest BTMD earnings report on Sep 30, 2025 announced Q3 2025 earnings of $8.2M, up 157.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTMD reported annual earnings of $3.2M, with -4.8% growth.
BTMD past earnings growth
How has BTMD's earnings growth performed historically?
On BTMD's earnings call on Invalid Date, Biote (NASDAQ: BTMD) reported Q3 2025 earnings per share (EPS) of $0.26, up 23.53% year over year. Total BTMD earnings for the quarter were $8.19 million. In the same quarter last year, Biote's earnings per share (EPS) was $0.34.
As of the last Biote earnings report, Biote is currently profitable. Biote's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $28.79 million, a 300.58% increase year over year.
What was BTMD's earnings growth in the past year?
As of Biote's earnings date in Invalid Date, Biote's earnings has grown 175.76% year over year. This is 164.09 percentage points higher than the US Medical Care Facilities industry earnings growth rate of 11.67%. BTMD earnings in the past year totalled $28.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.